2022-2026 UK Nucleic Acid Testing/NAT Market: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

Abstract

Highlights

• Comprehensive market segmentation analysis of the UK NAT market.
• Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
• An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
• Five-year test volume and reagent sales forecasts for the following categories:

• Review of testing methodologies and instrumentation technologies.
• Feature comparison of automated and semiautomated analyzers.
• Sales and market shares of leading suppliers.
• Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.
• Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

  Content
  Table of Contents
  I. Introduction
  II. Major Product Development Opportunities
  A. Instrumentation
  B. Reagent Kits and Test Systems/panels
  C. Computers, Software and Automation
  D. Auxiliary Products
  III. Design Criteria for Decentralized Testing Products
  IV. Alternative Market Penetration Strategies
  A. Internal Development
  B. Collaborative Arrangements
  C. University Contracts
  D. Distribution Strategies for Decentralized Testing Markets
  V. Potential Market Entry Barriers and Risks
  A. Market Maturity
  B. Cost Containment
  C. Competition
  D. Technological Edge and Limitations
  E. Patent Protection
  F. Regulatory Constraints
  G. Decentralized Testing Market Challenges
  VI. Market and Technology Review
  A. DNA Sequencing
  1. Introduction
  2. Sequencing Methods
  3. Autoradiography
  4. The Human Genome Project
  5. Sequencing Automation
  6. Image Scanners
  7. Fluorescent Detection
  8. Gene Profiling
  9. Gene Expression
  10. Polymorphism Screening
  11. Protein Interaction Networks
  B. DNA and RNA Probe Technologies
  1. Basic Principles
  2. Probe Preparation
  3. The DNA Probe Test
  4. Test Formats
  5. Labeling Techniques
  6. Amplification Methods
  C. Detection Technologies
  1. Radioactive Methods
  2. Non-Isotopic Methods
  D. Instrumentation
  Review of latest analyzers from Abbott, Beckm an Coulter/Danaher, Becton Dickinson, bioMerieux,
  Bio-Rad, Cepheid, Hologic, Qiagen, Roche, Siemens Healthineers, and others.
  E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
  - Liquid Transportation and Mixing
  - Separation
  - Reaction
  - Detection
  F. Pharmacogenomics
  G. Major Applications
  1. Microbiology/Infectious
  Diseases
  a. Overview
  b. Major Infectious
  Diseases
  - AIDS/HIV
  - Adenovirus
  - Aeromonads
  - Anthrax/Bacillus Anthracis
  - Arboviruses
  - Babesiosis
  - Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
  - Blastocystis Hominis
  - Brucella
  - Campylobacter
  - Candida
  - Chagas Disease
  - Chancroid
  - Chlamydia
  - Clostridium Difficile
  - Coronaviruses
  - Coxsackieviruses
  - Creutzfeldt-Jakob’s Disease
  - Cryptosporidium Parvum
  - Cyclospora Cayetanensis
  - Cytomegalovirus
  - Ebola Virus
  - E. Coli
  - EchoVirus
  - Encephalitis
  - Enteroviruses
  - Epstein-Barr Virus
  - Giardia Lamblia
  - Gonorrhea
  - Granuloma Inguinale
  - Hantavirus
  - Helicobacter Pylori
  - Hepatitis
  - Herpes Simplex Virus
  - Human Herpes Virus-6 (HHV-6)
  - Influenza Viruses
  - Legionella
  - Lyme Disease
  - Lymphogranuloma Venereum (LGV)
  - Malaria
  - Measles (Rubeo la)
  - Meningitis
  - Microsporidium
  - Mononucleosis
  - Mumps
  - Mycoplasma
  - Papillomaviruses
  - Parvovirus B19
  - Pneumonia
  - Polyomaviruses
  - Pseudomonas Aeruginosa
  - Rabies
  - Respiratory Syncytial Virus (RSV)
  - Rhinoviruses
  - Rotavirus
  - Rubella
  - Salmonellosis
  - Septicemia
  - Shigellosis
  - Staphylococcus Aureus
  - Streptococci
  - Syphilis
  - Toxoplasmosis
  - Trichomonas Vaginalis
  - Tuberculosis
  - Vibrio
  - West Nile Virus
  - Yersina
  - West Nile Virus
  - Yersina
  2. Cancer Testing
  a. Overview
  b. Major Cancer Types
  - Prostate
  - Lung
  - Colon and Rectum
  - Breast
  - Skin
  - Uterine
  - Leukemia
  - Oral
  c. Oncogenes
  The report provides review of both current and emerging oncogenes, including:
  - Abl/abl-bcr
  - AIB1
  - BCL-2
  - BRCA1
  - CD44
  - C-fos
  - C-myb
  - C-myc
  - CYP17
  - Erb-B
  - HPC1
  - N-myc
  - P40
  - P51
  - P53
  - PIK3CA
  - PTI-1
  - Ras
  - Reg
  - Sis
  - Src
  3. Genetic Diseases
  a. Overview
  b. Nucleic Acid Amplification
  c. Chromosome Imaging
  d. Genomics Technologies
  e. Proteomics Technologies
  f. Current Pharmacogenomic Tests
  g. Future Pharmacogenomic Testing
  h. Major Diseases
  - Achondroplasia
  - Autosomal Dominant Polycystic Kidney Disease
  - Cancer
  - Cosmetogenomics
  - Cystic Fibrosis
  - Down's Syndrome
  - Duchenne and Becker Muscular Dystrophy
  - Factor V (Leiden)
  - Factor IX Deficiency
  - Fragile X Syndrome
  - Heart Disease
  - Hemochomatosis
  - Hemophilia
  - Huntington's Disease
  - Maternal-Fetal Incompatibility
  - Multiple Endocrine Neoplasia
  - Phenylketonuria (PKU)
  - Polycystic Kidney Disease (PKD)
  - Prenatal Screening
  - Retinitis Pigmentosa
  - Retinoblastoma
  - Sickle Cell Anemia
  - Spinal Muscular Atrophy
  - Vitamin B12 Metabolism
  i. Social Issues and Concerns
  4. Forensic Testing
  a. Overview
  b. Multilocus and Single Locus Probes
  c. DNA Profile Data Banks
  d. Judicial Implementation
  e. Major Crime Categories
  f. Factors Contributing to the DNA Probe Market Expansion
  - Technology Availability
  - Use of Hair as Evidence
  g. Wildlife Forensics
  5. Paternity Testing/HLA Typing
  6. Other Applications
  a. Disease Susceptibility Testing
  b. Cardiovascular Diseases
  c. Diabetes
  d. Alzheimer's Disease
  e. Periodontal Disease
  f. Plasma Purification
  g. Organ Transplantation
  h. Water Contamination
  i. Other
  H. Competing/complementing
  1. Monoclonal Antibodies/Immunoassays
  2. RNA Probes
  3. Two-Dimensional Electrophoresis
  4. Flow Cytometry
  VII. Molecular Diagnostics Market
  A. Executive Summary
  B. Business Environment
  C. Market Structure
  D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
  VIII. Competitive Assessments
  The report provides strategic assessments of over 40 leading molecular diagnostics market players and
  start-up companies with innovative technologies and products, including:
  Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad,
  Cepheid, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols, Hologic, Illumina, LabCorp/Sequenom, Leica
  Biosystems, Myriad Genetics, Ortho-Clinical Diagnostics, Qiagen, Quest Diagnostics, Quidel, Roche,
  Shimadzu, Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher, Wako and
  others.
  IX. Appendix: Major Universities and Research Centers Developing Innovative
  Molecular Diagnostic Technologies and Products